منابع مشابه
Doctors and drug companies.
When a great profession and the forces of capitalism interact, drama is likely to result. This has certainly been the case where the profession of medicine and the pharmaceutical industry are concerned. On display in the relationship between doctors and drug companies are the grandeur and weaknesses of the medical profession — its noble aspirations and its continuing inability to fulfill them. ...
متن کاملOf doctor conventions and drug companies.
Pharmaceutical companies provide the majority of financial support for staging the American Academy of Family Physicians (AAFP) Annual Scientific Assembly. In return they are allowed to dominate the physical and mental environment. The assembly is opulent and entertaining, but undoubtedly much of the expense is passed to the health care consumer in the form of high-priced brand-name prescriptio...
متن کاملWhen Can Patients Sue Drug Companies?
Vol. 34 No. 5 • May 2009 • P&T® 243 (see the April issue of P&T, page 175). Ms. Levine sued and received a settlement from the clinic where the drug was administered. She also named Wyeth as a defendant, claiming that the drug’s label should have more clearly instructed clinicians against using an IV push injection. The label, which the FDA had approved, warned about inadvertent intra-arterial ...
متن کاملComputational Divided Differencing and Divided-Difference Arithmetics
Tools for computational differentiation transform a program that computes a numerical function F(x) into a related program that computes F ′(x) (the derivative of F). This paper describes how techniques similar to those used in computational-differentiation tools can be used to implement other program transformations—in particular, a variety of transformations for computational divided differen...
متن کاملDrug Companies Ask Plans To Just Say 'Yes' to Risk.
about its effectiveness will have to be high, and payers will need to be concerned about inappropriate use. Their four-year-old analysis of the factors needed for risk-sharing arrangements to succeed still rings true. Earlier this year, Aetna and Cigna signed deals with Novartis that link payments for its new heart failure medication, a valsartan–sacubitril combination (Entresto), to the hospit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 1990
ISSN: 0028-0836,1476-4687
DOI: 10.1038/345006a0